Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.
What happened
FDA reviewed the website www.inhousepharmacy.vu and found it offered domperidone drug products, including Vomistop (Domperidone 10mg) 500 Tablets/Pack, to U.S. consumers. FDA said domperidone is not approved for sale in the U.S. and cited serious cardiac risks, including cardiac arrhythmias, cardiac arrest, and sudden death.
What FDA found
The website offered domperidone drug products to U.S. consumers without FDA approval.
FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§331(d), 355(a)]Vomistop (Domperidone 10mg) 500 Tablets/Pack was offered without an approved drug application.
FD&C Act section 505(a) [21 U.S.C. §355(a)]FDA treats the products as unapproved new drugs because they are not generally recognized as safe and effective for their labeled uses.
FD&C Act section 201(p) [21 U.S.C. §321(p)]
What FDA wants
FDA asks the website to stop offering any unapproved drugs to U.S. consumers and to respond in writing within 15 working days describing steps taken and how it will prevent recurrence.
Who should pay attention
- U.S. consumers who buy prescription drugs online
- online pharmacies selling to U.S. customers
- companies distributing or marketing domperidone
This is a summary. Read the original letter on fda.gov.